Literature DB >> 12117977

Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis.

Muna Qadoumi1, Inge Becker, Norbert Donhauser, Martin Röllinghoff, Christian Bogdan.   

Abstract

Cytokine-inducible (or type 2) nitric oxide synthase (iNOS) is indispensable for the resolution of Leishmania major or Leishmania donovani infections in mice. In contrast, little is known about the expression and function of iNOS in human leishmaniasis. Here, we show by immunohistological analysis of skin biopsies from Mexican patients with local (LCL) or diffuse (DCL) cutaneous leishmaniasis that the expression of iNOS was most prominent in LCL lesions with small numbers of parasites whereas lesions with a high parasite burden (LCL or DCL) contained considerably fewer iNOS-positive cells. This is the first study to suggest an antileishmanial function of iNOS in human Leishmania infections in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117977      PMCID: PMC128200          DOI: 10.1128/IAI.70.8.4638-4642.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Effects of nitric oxide on the induction and differentiation of Th1 cells.

Authors:  W Niedbala; X Q Wei; D Piedrafita; D Xu; F Y Liew
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

2.  Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome.

Authors:  N Salaiza-Suazo; P Volkow; R Tamayo; H Moll; R Gillitzer; A Pérez-Torres; R Pérez-Montfort; J D Domínguez; O Velasco-Castrejón; M Crippa; I Becker
Journal:  Trop Med Int Health       Date:  1999-12       Impact factor: 2.622

3.  Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4.

Authors:  U Ritter; H Moll
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

4.  Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi.

Authors:  K R Gantt; T L Goldman; M L McCormick; M A Miller; S M Jeronimo; E T Nascimento; B E Britigan; M E Wilson
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

5.  Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment.

Authors:  D Little; S Khanolkar-Young; A Coulthart; S Suneetha; D N Lockwood
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 6.  Nitric oxide and the immune response.

Authors:  C Bogdan
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

Review 7.  Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens.

Authors:  C Nathan; M U Shiloh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

8.  Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction.

Authors:  G Cáceres-Dittmar; F J Tapia; M A Sánchez; M Yamamura; K Uyemura; R L Modlin; B R Bloom; J Convit
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis.

Authors:  P C Melby; F J Andrade-Narvaez; B J Darnell; G Valencia-Pacheco; V V Tryon; A Palomo-Cetina
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

10.  Fibroblasts as host cells in latent leishmaniosis.

Authors:  C Bogdan; N Donhauser; R Döring; M Röllinghoff; A Diefenbach; M G Rittig
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

View more
  25 in total

1.  Immunomodulatory peptide from cystatin, a natural cysteine protease inhibitor, against leishmaniasis as a model macrophage disease.

Authors:  Snigdha Mukherjee; Anindita Ukil; Pijush K Das
Journal:  Antimicrob Agents Chemother       Date:  2007-03-05       Impact factor: 5.191

2.  A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.

Authors:  Patricio López-Jaramillo; Melvin Y Rincón; Ronald G García; Sandra Y Silva; Erin Smith; Piyaporn Kampeerapappun; Carlos García; Daniel J Smith; Marcos López; Iván D Vélez
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

3.  Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200.

Authors:  Mauro Cortez; Chau Huynh; Maria Cecilia Fernandes; Kathleen A Kennedy; Alan Aderem; Norma W Andrews
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

4.  Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis.

Authors:  Arturo A Wilkins-Rodríguez; Armando Pérez-Torres; Alma R Escalona-Montaño; Laila Gutiérrez-Kobeh
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

5.  Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.

Authors:  Cláudia Maria Castro Gomes; Maria Gloria Teixeira Sousa; Joyce Prieto Bezerra Menezes; Marliane Campos Batista; Ana Carolina Stocco Lima; Walter Belda; Daniel Bradshaw; Monica Elinor Alves Gama; Márcia Dalastra Laurenti; Fernando Tobias Silveira; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2017-02-21       Impact factor: 2.289

6.  Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.

Authors:  Paulo E A Souza; Manoel O C Rocha; Cristiane A S Menezes; Janete S Coelho; Andréa C L Chaves; Kenneth J Gollob; Walderez O Dutra
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

Review 7.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Protection of Mycobacterium tuberculosis from reactive oxygen species conferred by the mel2 locus impacts persistence and dissemination.

Authors:  Suat L G Cirillo; Selvakumar Subbian; Bing Chen; Torin R Weisbrod; William R Jacobs; Jeffrey D Cirillo
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

9.  Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

Authors:  F Janaina Soares Rocha; Ulrike Schleicher; Jochen Mattner; Gottfried Alber; Christian Bogdan
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 10.  Cutaneous leishmaniasis: immune responses in protection and pathogenesis.

Authors:  Phillip Scott; Fernanda O Novais
Journal:  Nat Rev Immunol       Date:  2016-07-18       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.